Sollentuna, Sweden

Hans Uno Sievertsson

This inventor holds 2 USPTO granted patents. Top assignee: Ab Kabi. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Uno Sievertsson. Retrieved from https://idiyas.com/inventor/hans-uno-sievertsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hans Uno Sievertsson

Introduction

Hans Uno Sievertsson is a notable inventor based in Sollentuna, Sweden. He has made significant contributions to the field of synthetic peptides, holding two patents that showcase his innovative work. His research focuses on the development of peptides that promote growth in mammalian tissues.

Latest Patents

Sievertsson's latest patents include "Synthetic peptides having growth promoting activity" and "Growth promoting polypeptides and preparation method." The first patent describes novel synthetic peptides that can be produced in cyclic form through oxidation, which are useful in promoting cell growth. The second patent outlines a growth-promoting polypeptide with specific molecular weight and chromatographic mobility, detailing a method for deriving these polypeptides from blood serum or plasma.

Career Highlights

Hans Uno Sievertsson is associated with Ab Kabi, where he continues to advance his research in synthetic peptides. His work has implications in various fields, including medicine and biotechnology, where growth-promoting agents are essential.

Collaborations

Some of his notable coworkers include Linda Fryklund and Knut Oivind Uthne, who have contributed to his research endeavors.

Conclusion

Hans Uno Sievertsson's innovative work in synthetic peptides has the potential to impact the growth of mammalian tissues significantly. His patents reflect a commitment to advancing scientific knowledge and practical applications in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…